Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Gary Kurtzman
AddedMar 31, 2024
UpdatedMay 31, 2026
Gary Kurtzman

Gary Kurtzman

Board Member, Oncora Medical

CrunchbaseLinkedIn

Gary Kurtzman's Career

Oncora Medical
Oncora Medical

Philadelphia, PA, US

Board Member· Board
MedCrypt
MedCrypt

Encinitas, CA, US

Board Member· Board
PixelOptics
PixelOptics

Roanoke, VA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Gary Kurtzman's Career

Oncora Medical
Oncora Medical
Seed$7M302014Philadelphia, PA, US
Board Member· Board

Leadership at Oncora Medical

Christopher BerlindChristopher BerlindCo-Founder
David LindsayDavid LindsayCo-Founder

Similar to Oncora Medical

Onc.AIOnc.AISan Carlos, CA, USOncology Softwareest. 2020Onc.AISan Carlos, CA, US · est. 2020

Creating precision oncology software for clinical use, with a focus on physician-centered products.

Series A · $31M30
OncospaceOncospaceBaltimore, MD, USMedical Devicesest. 2019OncospaceBaltimore, MD, US · est. 2019

Oncospace: AI-driven medical device manufacturer specializing in personalized radiation oncology treatments.

Pre-Seed · $1.3M20
OncoLensOncoLensAtlanta, GA, USTumor Board Softwareest. 2016OncoLensAtlanta, GA, US · est. 2016

OncoLens: Streamlining cancer case reporting with our efficient tumor board software solution.

Series A · $11.8M39
Onko SolutionsOnko SolutionsAustin, TX, USCancer Detection, Cancer Treatmentest. 2014Onko SolutionsAustin, TX, US · est. 2014

Onko Solutions: Innovating accurate cancer detection, prevention, and treatment for underserved communities.

Series A · $2.5M8
MedCrypt
MedCrypt
Series B$34.4M592016Encinitas, CA, US
Board Member· Board

Leadership at MedCrypt

Mike KijewskiMike KijewskiCo-Founder
Eric PancoastEric PancoastFounder
Mike KijewskiMike KijewskiCo-Founder
Michael McNeilMichael McNeilBoard Member

Similar to MedCrypt

CynerioCynerioNew York City, NY, USSecurity Softwareest. 2017CynerioNew York City, NY, US · est. 2017

Cynerio: Ensuring data protection and patient safety through secure healthcare IoT solutions.

Series B · $37M79
MedcurityMedcuritySpokane, WA, USCompliance Platformest. 2018MedcuritySpokane, WA, US · est. 2018

Medcurity develops a compliance management platform for complex HIPAA and healthcare system security.

Angel · $1.6M14
CulindaCulindaFrisco, TX, USCybersecurity, Softwareest. 2018CulindaFrisco, TX, US · est. 2018

Culinda: Expert cybersecurity solutions for medical IoT devices.

Seed · $1M25
Heal SecurityHeal SecurityMenlo Park, CA, USest. 2021Heal SecurityMenlo Park, CA, US · est. 2021

HEAL Security: Pioneering healthcare cybersecurity, providing real-time risk insights, enhancing cyber resilience, and safeguarding patient care.

Seed · $4.6M13
PixelOptics
PixelOptics
Series A$146.3M302005Roanoke, VA, US
Board Member· Board

Leadership at PixelOptics

Brett CraigBrett CraigBoard Member
Ron BlumRon BlumFounder
Brian J StarkBrian J StarkBoard Member

Gary Kurtzman's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Gary Kurtzman

Ricky RegaladoRicky RegaladoCo-Founder · RouteCraig RidleyCraig RidleyCo-Founder · RouteMike MorenoMike MorenoCo-Founder · RouteEvan WalkerEvan WalkerCEO · RouteRicky FunkRicky FunkCo-Founder · RouteThomas BoothThomas BoothCo-Founder · Route